STOCK TITAN

Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)

SAN DIEGO, CA / ACCESSWIRE / January 4, 2023 / (OTC:PLPL) Plandai Biotechnology, Inc. ("Plandai" or the "Company") announces the termination of its previously announced asset acquisition agreement with EV Hotel Corp., a Georgia corporation. The termination was agreed to by both parties, and the Company incurred no penalties, costs, or liabilities in connection with the termination.

The Company completed its two-year independent audit of its financial statements and will use them as a basis for future disclosures and its continuing merger and acquisition efforts.

About:

Plandai Biotechnology, Inc., a Nevada corporation, is a publicly quoted shell company seeking to create value for its shareholders by merging with another entity with experienced management and opportunities for growth.

Contact:

plandai@protonmail.com

SOURCE: Plandai Biotechnology



View source version on accesswire.com:
https://www.accesswire.com/733839/Plandai-Biotechnologies-Inc-Announces-Termination-of-Asset-Acquisition-Agreement-with-EV-Hotel-Updates-on-Status-of-Independent-Audit

PLANDAI BIOTECHNOLOGY INC

OTC:PLPL

PLPL Rankings

PLPL Latest News

PLPL Stock Data

236.87k
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
London

About PLPL

plandaã­ biotechnology, inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. it is developing phytofare catechin complex, a botanical extract derived from green tea harvested in the senteeko tea estate in mpumalanga, south africa; and phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, artemisia, and cannabis. the company also produces and sells timber and agricultural products from its farm and tea estate holdings in south africa. plandaã­ biotechnology, inc. is based in london, the united kingdom.